These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27221871)

  • 21. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
    Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
    Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma.
    Asadi M; Shanehbandi D; Mohammadpour H; Hashemzadeh S; Sepehri B
    J Gastrointest Cancer; 2019 Jun; 50(2):304-307. PubMed ID: 29453761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901.
    Fan H; Jiang M; Li B; He Y; Huang C; Luo D; Xu H; Yang L; Zhou J
    Oncol Rep; 2018 Mar; 39(3):1207-1214. PubMed ID: 29328491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer.
    Chen C; Liu X; Chen C; Chen Q; Dong Y; Hou B
    Ann Clin Lab Sci; 2019 May; 49(3):302-308. PubMed ID: 31308028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-34a modulates ErbB2 in breast cancer.
    Wang Y; Zhang X; Chao Z; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
    Cell Biol Int; 2017 Jan; 41(1):93-101. PubMed ID: 27813227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
    Li P; Guo Y; Bledsoe G; Yang Z; Chao L; Chao J
    Exp Cell Res; 2016 Jan; 340(2):305-14. PubMed ID: 26790955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells.
    Stankevicins L; Almeida da Silva AP; Ventura Dos Passos F; Dos Santos Ferreira E; Menks Ribeiro MC; G David M; J Pires E; Ferreira-Machado SC; Vassetzky Y; de Almeida CE; de Moura Gallo CV
    Radiat Oncol; 2013 Oct; 8():231. PubMed ID: 24094113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
    Wen J; Zhao YK; Liu Y; Zhao JF
    Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
    Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
    Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells.
    Xie YL; Yang YJ; Tang C; Sheng HJ; Jiang Y; Han K; Ding LJ
    Clin Transl Oncol; 2014 Oct; 16(10):898-905. PubMed ID: 24643702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer.
    Shekari N; Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Anticancer Agents Med Chem; 2019; 19(3):304-309. PubMed ID: 30543177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
    Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells.
    Wu H; Huang M; Liu Y; Shu Y; Liu P
    Technol Cancer Res Treat; 2015 Dec; 14(6):747-55. PubMed ID: 24988056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.
    Lin Z; Li JW; Wang Y; Chen T; Ren N; Yang L; Xu W; He H; Jiang Y; Chen X; Liu T; Liu G
    Clin Lab; 2016; 62(1-2):121-8. PubMed ID: 27012041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
    Hu Y; Pu Q; Cui B; Lin J
    Int J Clin Exp Pathol; 2015; 8(8):8921-8. PubMed ID: 26464633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.